Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03448991 · ClinicalTrials.gov registry record

Effect of NPO Time and Type of Food Intake on Preoperative Residual Gastric Content and pH

A clinical trial, sponsored by Boston Children's Hospital.

Completed
Registry status
150
Enrollment target

NCT03448991: Completed study, sponsored by Boston Children's Hospital.

NCT03448991 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03448991 has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
150 participants
Enrollment target

Study Summary

According to normal physiology, the longer fasting period allows food particles to pass stomach through small intestines to minimize intragastric content. The practice guidelines recommend 2-hour fasting period for clear fluid (including water, pulp-free juice and tea or coffee without milk), 4- hour fasting period for breast milk and 6-hour fasting period for non-human milk and solid food to reduce risks of pulmonary aspiration. As a result of longer fasting period, patients tend to experience preoperative dehydrated states and intraoperative hypotension. Patients' demographic data will be obtained from charts. Parents will be asked for type, volume of fluid/food intake and NPO time. This study will be done at BCH's Gastroenterology Procedure Unit (GPU) theaters to measure actual intragastric volume and pH at the beginning esopagogastroduodenoscopy procedures. We hope to demonstrate the relationship between NPO time and actual intragastric volume which provide sufficient data of NPO time to ensure patient's safety.

Primary Outcome

Actual intragastric content volume (ml) which is suctioned from each pediatric patient is measured

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2018-08-24
Est. Completion 2019-12-11
Boston Children's Hospital

462 total trials

What the finished NCT03448991 record still lists

NCT03448991 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT03448991 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03448991 about?

NCT03448991 is a clinical study titled "Effect of NPO Time and Type of Food Intake on Preoperative Residual Gastric Content and pH". According to normal physiology, the longer fasting period allows food particles to pass stomach through small intestines to minimize intragastric content. The practice guidelines recommend 2-hour fasting period for clear fluid (including water, pulp-free juice and tea or coffee without milk), 4- hou...

What is the current status of trial NCT03448991?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2018-08-24. Estimated completion is 2019-12-11.

Who is sponsoring clinical trial NCT03448991?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03448991, the US trial registry maintained by the National Library of Medicine. NCT03448991 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.